Sun Pharma Announces Successful Taro Merger
Company Announcements

Sun Pharma Announces Successful Taro Merger

Taro Pharmaceutical (TARO) has released an update.

Sun Pharmaceutical Industries Limited has announced the completion of its merger with Taro Pharmaceutical Industries Ltd., making Taro a wholly-owned subsidiary and private entity. The merger is anticipated to enhance the combined entity’s competitive edge in the generic pharmaceuticals market. Sun Pharma, the majority shareholder of Taro since 2010, aims to leverage the merged strengths to foster growth and success.

For further insights into TARO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskTaro Pharmaceutical Greenlights Merger With Sun Pharma
TheFlyTaro Pharmaceutical approve Merger with Sun Pharma
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App